Kewaunee Scientific Corporation (KEQU) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Kewaunee Scientific Corporation (KEQU) trades at $36.47 with AI Score 52/100 (Grade B). Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture. Market cap: $105M, Sector: Consumer cyclical.
Price as of Aug 21, 2026 · Last analyzed: May 10, 2026Analyst Coverage for KEQU: KEQU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KEQU against Consumer Cyclical peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
KEQU: 1/3 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Kewaunee Scientific Corporation (KEQU) Consumer Business Overview
Kewaunee Scientific Corporation, founded in 1906, specializes in designing, manufacturing, and installing laboratory, healthcare, and technical furniture. Operating through Domestic and International segments, the company provides a diverse product range, including steel, wood, and laminate furniture, serving pharmaceutical, biotechnology, and healthcare markets with a P/E ratio of 9.7.
What Is the Investment Thesis for KEQU?
Kewaunee Scientific Corporation presents a compelling investment case based on its established market position and diverse product offerings. With a P/E ratio of 9.7 and a gross margin of 28.9%, the company demonstrates financial stability. Growth catalysts include expansion in the healthcare and biotechnology sectors, driven by increased R&D spending. The company's international segment also presents growth opportunities. Potential risks include economic downturns affecting capital spending in the laboratory and healthcare sectors, as well as competition from other furniture manufacturers. The company's beta of 0.67 suggests lower volatility compared to the broader market.
Based on FMP financials and quantitative analysis
KEQU Key Highlights
Market capitalization of $105M indicates a small-cap company with potential for growth.
- P/E ratio of 9.7 suggests the company may be undervalued compared to its earnings.
- Gross margin of 28.9% reflects the company's ability to manage production costs effectively.
- Profit margin of 3.9% indicates profitability, though there is room for improvement.
- Beta of 0.67 suggests lower volatility compared to the overall market, potentially making it a more stable investment.
Who Are KEQU's Competitors?
KEQU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| VCCTF Victoria PLC | $0.79 | +0.00% | $91.1M | 43 |
| NVFY Nova LifeStyle, Inc. | $6.18 | -0.80% | $85.2M | 51 |
| WKGBF Sanderson Design Group plc | $1.01 | +0.00% | $73.0M | 51 |
| HOFT Hooker Furnishings Corporation | $14.32 | -0.66% | $154M | 47 |
| BSET Bassett Furniture Industries, Incorporated | $18.62 | -1.27% | $161M | 62 |
| LCUT Lifetime Brands, Inc. | $9.30 | -1.17% | $213M | 78 |
| VIOT Viomi Technology Co., Ltd | $0.70 | +0.00% | $47.6M | 46 |
| LOVE The Lovesac Company | $16.27 | -4.52% | $238M | 59 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KEQU's Key Strengths?
Long-standing history and established reputation.
- Diverse product portfolio serving multiple industries.
- Global presence through Domestic and International segments.
- Comprehensive solutions including design and installation services.
What Are KEQU's Weaknesses?
Relatively small market capitalization.
- Lower profit margin compared to some competitors.
- Dependence on capital spending in specific sectors.
- Limited brand recognition compared to larger furniture manufacturers.
What Could Drive KEQU Stock Higher?
Increased R&D spending in the pharmaceutical and biotechnology sectors driving demand for laboratory furniture.
- Expansion of healthcare facilities and diagnostic laboratories creating opportunities for growth.
- Potential new product launches featuring innovative designs and technologies by Q4 2026.
- Strategic partnerships with key industry players to expand market reach.
What Are the Key Risks for KEQU?
Economic downturns affecting capital spending in the laboratory and healthcare sectors.
- Intense competition from other furniture manufacturers.
- Fluctuations in raw material prices impacting production costs.
- Changes in regulatory requirements affecting laboratory and healthcare industries.
- Disruptions in the supply chain due to global events.
What Are the Growth Opportunities for KEQU?
- Expansion in the Healthcare Sector: The increasing demand for advanced healthcare facilities and diagnostic laboratories presents a significant growth opportunity for Kewaunee. The healthcare sector is experiencing substantial growth, driven by an aging population and advancements in medical technology. Kewaunee can capitalize on this trend by offering specialized furniture and infrastructure solutions for hospitals, clinics, and research institutions. This market is estimated to reach $400 billion by 2028, providing a substantial runway for growth.
- Penetration of the Biotechnology Market: The biotechnology industry is experiencing rapid growth, fueled by advancements in genetic engineering and personalized medicine. This growth is driving demand for advanced laboratory facilities and equipment. Kewaunee can leverage its expertise in designing and manufacturing laboratory furniture to capture a larger share of this market. The global biotechnology market is projected to reach $1 trillion by 2027, offering significant growth potential for Kewaunee.
- Growth in International Markets: Kewaunee's international segment presents a significant growth opportunity. Emerging markets, particularly in Asia and Latin America, are experiencing rapid economic growth and increasing investments in research and development. Kewaunee can expand its presence in these markets by establishing strategic partnerships and offering customized solutions tailored to local needs. The international laboratory furniture market is expected to grow at a CAGR of 6% over the next five years.
- Product Innovation and Development: Continuous innovation in product design and functionality is crucial for maintaining a competitive edge. Kewaunee can invest in research and development to create new and improved products that meet the evolving needs of its customers. This includes developing modular and flexible furniture systems, as well as integrating advanced technologies such as automation and robotics into its products. Investing in R&D can lead to higher margins and increased market share.
- Strategic Acquisitions and Partnerships: Kewaunee can pursue strategic acquisitions and partnerships to expand its product portfolio and geographic reach. Acquiring complementary businesses can provide access to new technologies, markets, and customers. Forming partnerships with other companies can also enhance Kewaunee's capabilities and competitiveness. For example, partnering with a company specializing in laboratory automation could enhance Kewaunee's product offerings and attract new customers.
What Are KEQU's Competitive Advantages?
- Established brand reputation since 1906.
- Diverse product portfolio catering to multiple sectors.
- Strong distribution network through dealers, subsidiaries, and national distributors.
- Expertise in designing and manufacturing specialized furniture solutions.
What Does KEQU Do?
Founded in 1906, Kewaunee Scientific Corporation has evolved into a leading designer, manufacturer, and installer of laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two primary segments: Domestic and International. Kewaunee's comprehensive product portfolio includes steel, wood, and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories. These products cater to a diverse range of applications, including chemistry, physics, biology, and general science laboratories. Kewaunee serves the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and healthcare markets. The company also provides technical products for facilities manufacturing computers and light electronics, as well as laminate caseworks for educational, healthcare, and industrial settings. Kewaunee distributes its products through dealers, subsidiaries, and a national distributor, maintaining a strong presence in both domestic and international markets. Headquartered in Statesville, North Carolina, Kewaunee Scientific Corporation continues to innovate and adapt to the evolving needs of its diverse customer base.
What Products and Services Does KEQU Offer?
- Designs and manufactures laboratory furniture.
- Provides healthcare furniture solutions.
- Offers technical furniture for computer and electronics manufacturing facilities.
- Installs furniture and infrastructure products.
- Operates through Domestic and International segments.
- Provides design services related to its products.
How Does KEQU Make Money?
- Manufactures and sells laboratory, healthcare, and technical furniture.
- Generates revenue through product sales and installation services.
- Distributes products through dealers, subsidiaries, and a national distributor.
What Industry Does KEQU Operate In?
Kewaunee Scientific Corporation operates in the furnishings, fixtures, and appliances industry, which is influenced by construction spending, R&D investments, and economic cycles. The laboratory furniture market is expected to grow, driven by advancements in biotechnology and pharmaceutical research. Competition includes both large furniture manufacturers and specialized laboratory equipment providers. Kewaunee differentiates itself through its comprehensive product range and its focus on both domestic and international markets. The company's ability to adapt to changing industry trends and customer needs will be crucial for maintaining its competitive edge.
Who Are KEQU's Key Customers?
- Pharmaceutical companies
- Biotechnology firms
- Educational institutions (universities and schools)
- Healthcare facilities (hospitals and clinics)
- Industrial and chemical companies
- Government and research institutions
Forward Outlook
Wall Street analysts project Kewaunee Scientific Corporation revenue of about $150.8M for fiscal 2026, with EPS near $1.53.
Financial Health
Kewaunee Scientific Corporation's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.44 places it in the safe zone, indicating low near-term bankruptcy risk.
Key Financial Metrics
Return on equity for Kewaunee Scientific Corporation stands at 13.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.4%, showing how much profit it generates from its asset base. KEQU trades at a trailing price-to-earnings ratio of 9.70, below the Consumer Cyclical sector average of ~34x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.18 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 9.2%, the inverse of the P/E and a quick read on earnings relative to price.
Kewaunee Scientific Corporation (KEQU) Valuation Context
Valued at $105M, KEQU is classified as a micro-cap stock. Relative to its peer group, KEQU's quantitative score of 52/100 is roughly in line with the peer average of 51/100.
KEQU Revenue & Earnings Trend
In Q2 2026, KEQU generated $71.4M in top-line revenue, marking a sequential increase of 2.9%. The company recorded net income of $3.4M, with diluted EPS of $1.13. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Cyclical. Across the four most recent quarters, KEQU averaged $0.80 in diluted EPS.
Company Profile
Kewaunee Scientific Corporation operates in the Furnishings, Fixtures & Appliances industry within the Consumer Cyclical sector. It is headquartered in Statesville, US. The company is led by CEO Thomas David Hull. KEQU has traded publicly since 1980.
KEQU Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that leadership believes in upcoming growth opportunities.
- Community sentiment has shifted positively as discussions around Kewaunee's innovative product lines gain traction, reflecting optimism.
- The company has been expanding its market reach, particularly in laboratory and healthcare sectors, which are expected to grow significantly.
- Recent partnerships and contracts have been announced, enhancing Kewaunee's visibility and potential revenue streams in a competitive landscape.
Bear Case
- Concerns about supply chain disruptions have emerged, potentially impacting production timelines and operational efficiency.
- Some community members express skepticism regarding the sustainability of recent growth, fearing it may not be reflective of long-term trends.
- Kewaunee's reliance on specific sectors could pose risks if market dynamics change, leading to vulnerability in revenue streams.
- Negative sentiment has surfaced regarding the overall economic outlook, which could dampen demand for Kewaunee's products in the near term.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $71M | $3M | $1.13 |
| Q1 2026 | $69M | $692,000 | $0.23 |
| Q4 2025 | $70M | $2M | $0.82 |
| Q3 2025 | $71M | $3M | $1.04 |
Based on FMP financials and quantitative analysis
KEQU Latest News
-
Earnings Scheduled For June 23, 2026
benzinga · Jun 23, 2026
KEQU Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KEQU.
Price Targets
Wall Street price target analysis for KEQU.
KEQU MoonshotScore
What does this score mean?
The MoonshotScore rates KEQU 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Classification
Industry Furnishings, Fixtures & AppliancesLeadership: Thomas David Hull
CEO
Thomas David Hull serves as the CEO of Kewaunee Scientific Corporation, leading a team of 1006 employees. His career history includes extensive experience in the manufacturing and industrial sectors. He has held various leadership positions, demonstrating expertise in strategic planning, operational management, and business development. Hull's educational background includes a degree in engineering and an MBA from a leading business school, providing him with a strong foundation in both technical and business principles.
Track Record: Under Thomas David Hull's leadership, Kewaunee Scientific Corporation has focused on expanding its presence in key markets and enhancing its product offerings. Key achievements include the successful integration of new technologies into the company's manufacturing processes and the implementation of strategic initiatives to improve operational efficiency. Hull has also overseen the expansion of the company's international segment, driving growth in emerging markets.
KEQU Consumer Cyclical Stock FAQ
What does the AI Score mean for KEQU?
KEQU holds an AI Score of 52/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture. The company operates through its Domestic and International segments, providing …
What does Kewaunee Scientific Corporation do?
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through its Domestic and International segments, offering a range of products including steel, wood, and laminate furniture, fume hoods, biological safety cabinets, and related accessories.
What do analysts say about KEQU stock?
Analyst coverage of Kewaunee Scientific Corporation (KEQU) is limited, but key valuation metrics suggest potential undervaluation. The company's P/E ratio of 9.7 is relatively low compared to the industry average, indicating potential for earnings growth. Growth considerations include expansion in the healthcare and biotechnology sectors, as well as penetration of international markets.
What are the main risks for KEQU?
Kewaunee Scientific Corporation faces several risks, including economic downturns affecting capital spending in the laboratory and healthcare sectors. Intense competition from other furniture manufacturers could also impact market share and profitability. Fluctuations in raw material prices, such as steel and wood, could increase production costs and reduce margins.
What are the key factors to evaluate for KEQU?
Kewaunee Scientific Corporation (KEQU) holds an AI score of 52/100 (moderate). P/E: 9.7x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does KEQU data refresh on this page?
KEQU's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven KEQU's recent stock price performance?
Kewaunee Scientific Corporation (KEQU) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Long-standing history and established reputation. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider KEQU overvalued or undervalued right now?
Kewaunee Scientific Corporation (KEQU) trades at 9.7x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research KEQU before investing?
Before investing in Kewaunee Scientific Corporation (KEQU), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data as of 2026-05-10.
- Financial metrics are based on the most recent filings.
- Analyst opinions may vary.